ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

NICE backs Europe’s first stem cell therapy – PMLiVE

Continue reading

2017-08-25 Michael Zand NEWS

Intriguing data with Juno’s new CAR-T therapy – PMLiVE


PMLiVE

NICE backs Europe’s first stem cell therapy
PMLiVE
Chiesi made history two years ago when it claimed the first approval in Europe for a stem cell therapy, and can now celebrate decision by NICE to recommend its product for routine use in England and Wales. The therapy – called Holoclar – was approved …

Continue reading

2017-08-25 Michael Zand NEWS

Intriguing data with Juno’s new CAR-T therapy – PMLiVE

Intriguing data with Juno’s new CAR–T therapy
PMLiVE
“The discovery of methods of reactivating CAR–T cells may further augment their efficacy,” write the authors. That is important as studies with CAR-T to date have shown that some patients quickly relapse after an initial response and – while re …

Continue reading

2017-08-25 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving Average – Modern Readers

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving AverageModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pre… Continue reading

2017-08-25 Michael Zand NEWS

Malware coded into synthetic genomes – We Live Security (blog)

We Live Security (blog)Malware coded into synthetic genomesWe Live Security (blog)In the hypothetical case that a piece of modified DNA has been successfully synthesized, then the malicious code could form a part of a synthetic cell capable of replicat… Continue reading

2017-08-25 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving Average – Highlight Press

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving AverageHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pr… Continue reading

2017-08-25 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving Average – Modern Readers

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 10.2% Above Its 50 Day Moving AverageModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pre… Continue reading

2017-08-25 Michael Zand NEWS

Could activating stem cells promote hair growth? UCLA scientists think they’ve found the metabolic root – STAT

Intriguing data with Juno’s new CAR–T therapy
PMLiVE
“The discovery of methods of reactivating CAR–T cells may further augment their efficacy,” write the authors. That is important as studies with CAR-T to date have shown that some patients quickly relapse after an initial response and – while re …

Continue reading

2017-08-25 Michael Zand NEWS
  • 1
  • …
  • 1,307
  • 1,308
  • 1,309
  • 1,310
  • 1,311
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

STAT

Could activating stem cells promote hair growth? UCLA scientists think they’ve found the metabolic root
STAT
The study, published in Nature Cell Biology 1, finds that the metabolism in the stem cells embedded in hair follicles is different from surrounding cells. When they tinkered with that metabolic pathway in mice, they could either halt hair growth — or …